This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Dextrose 20% Injection USP
- Starting date:
- January 30, 2013
- Posting date:
- February 18, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-23309
Recalled Products
Dextrose 20% Injection USP
Reason
Lot# 21105JT is recalled as sampling results did not meet the Acceptable Quality Level (AQL) for primary bag leaks during visual inspection.
Depth of distribution
Wholesalers and hospitals in Canada.
Affected products
Dextrose 20% Injection USP
DIN, NPN, DIN-HIM
DIN 00037966
Dosage form
Solution
Strength
200 mg/mL
Lot or serial number
Lot 21105JT
Companies
- Recalling Firm
-
Hospira Healthcare Corporation Suite 600 - 1111 Dr. Frederik Philips Blvd, Saint-Laurent, Quebec H4M 1X6
- Marketing Authorization Holder
-
Hospira Healthcare Corporation Suite 600 - 1111 Dr. Frederik Philips Blvd, Saint-Laurent, Quebec H4M 1X6